Table 3.
Serum and urinary albumin and microprotein: control, diabetic, diabetic rats treated with nanoemulsified garlic oil blend (Dia + GNE) and diabetic rats treated garlic oil blend (Dia + GO), diabetic rats treated with atorvastatin (Dia + Ator)
Urine and serum parameters | Control | Diabetic | Dia + GNE | Dia + GO | Dia + Ator |
---|---|---|---|---|---|
Urinary albumin: creatinine ratio | |||||
M1 | 40.5 ± 3.52 | 97.3 ± 5.02a* | 101 ± 3.4 | 109.3 ± 3.7 | 114.3 ± 4.69 |
M3 | 42 ± 2.2 | 355 ± 14.5a** | 123 ± 3.4b** | 341 ± 5.4c*** | 215 ± 12c* |
M5 | 43 ± 2.3 | 513 ± 30.2a** | 88 ± 6.25b** | 201 ± 13.1b*c* | 250.3 ± 9.0b*c** |
Urinary microprotein: creatinine ratio | |||||
M1 | 296 ± 3.92 | 755 ± 24.8a** | 547 ± 6.13b* | 700.2 ± 14.8c** | 282 ± 10.1b**c***d*** |
M3 | 296 ± 3.53 | 1189 ± 33.4a*** | 932 ± 4.02b* | 931.5 ± 7.02b* | 906.2 ± 10.8b*c*d* |
M5 | 298 ± 1.82 | 1907 ± 35.6a*** | 518 ± 9.09b*** | 623 ± 4.6b***c* | 1100 ± 8.76b**c****d**** |
Serum albumin | |||||
M1 | 4.1 ± 0.04 | 3.8 ± 0.04 | 3.6 ± 0.036 | 3.8 ± 0.03 | 3.39 ± 0.02 |
M3 | 4.20 ± 0.04 | 3.5 ± 0.04a* | 3.8 ± 0.03b*** | 3.5 ± 0.06 | 3.24 ± 0.02c*d** |
M5 | 4.05 ± 0.05 | 2.3 ± 0.05a** | 4.05 ± 0.03b** | 3.8 ± 0.044b* | 3.4 ± 0.04b*c*** |
Serum protein | |||||
M1 | 8.05 ± 0.05 | 7.7 ± 0.051a* | 7.5 ± 0.02 | 7.3 ± 0.023 | 7.2 ± 0.04 |
M3 | 8.23 ± 0.04 | 6.77 ± 0.054a** | 6.8 ± 0.03 | 6.4 ± 0.016 | 6.6 ± 0.02 |
M5 | 8.01 ± 0.04 | 6.4 ± 0.05a*** | 7.6 ± 0.03b** | 7.4 ± 0.016b*c* | 7.2 ± 0.02b*c*d** |
M Month. Values represent the mean ± standard error (n = 6) of the samples. Significant difference between Control and Diabetic groups: a*p < 0.05, a**p < 0.001, a***p < 0.001. Significant difference between Diabetic and Dia + GNE, Dia + GO, Dia + Ator: b*p < 0.05, b**p < 0.01, b***p < 0.001. Significant difference between Dia + GNE and Dia + GO, Dia + GNE and Dia + Ator: c*p < 0.05, c**p < 0.01, c***p < 0.001, c****p < 0.0001. Significant difference between Dia + GO and Dia + Ator: d**p < 0.01, d***p < 0.001, d****p < 0.0001